NCT07565844 Intradermal Exosomes, Platelet-Rich Plasma, and Steroids for Post-Herpetic Neuralgia Status RECRUITING Phase NA
NCT07340723 Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease ) Status RECRUITING Phase PHASE2
NCT07297914 Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT06585774 A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease Status RECRUITING Phase PHASE3
NCT06521762 Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis Status WITHDRAWN Phase PHASE2
NCT06388564 A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06141161 Assessment of Bronchial Asthma Among Patients Attending Sohag University Hospital Status RECRUITING Phase N/A
NCT06019507 A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05899725 The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Pneumonia Status RECRUITING Phase NA
NCT05653349 Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05643638 A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD Status RECRUITING Phase PHASE2
NCT05468320 Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura Status COMPLETED Phase PHASE3
NCT05207358 Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis Status RECRUITING Phase PHASE4
NCT05156710 BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05123040 Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids Status TERMINATED Phase PHASE1/PHASE2
NCT04877288 A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications Status RECRUITING Phase PHASE3
NCT04849533 Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial) Status UNKNOWN Phase PHASE4